KR20070107043A - 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 타르트레이트 및 말레이트 염 - Google Patents
트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 타르트레이트 및 말레이트 염 Download PDFInfo
- Publication number
- KR20070107043A KR20070107043A KR1020077018678A KR20077018678A KR20070107043A KR 20070107043 A KR20070107043 A KR 20070107043A KR 1020077018678 A KR1020077018678 A KR 1020077018678A KR 20077018678 A KR20077018678 A KR 20077018678A KR 20070107043 A KR20070107043 A KR 20070107043A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- salt
- disorders
- crystalline
- schizophrenia
- Prior art date
Links
- BYPMJBXPNZMNQD-PZJWPPBQSA-N CC(C)(C1)N(C)CCN1[C@H](C1)c2cc(Cl)ccc2[C@@H]1c1ccccc1 Chemical compound CC(C)(C1)N(C)CCN1[C@H](C1)c2cc(Cl)ccc2[C@@H]1c1ccccc1 BYPMJBXPNZMNQD-PZJWPPBQSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200500238 | 2005-02-16 | ||
DKPA200500238 | 2005-02-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20070107043A true KR20070107043A (ko) | 2007-11-06 |
Family
ID=38006636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077018678A KR20070107043A (ko) | 2005-02-16 | 2006-02-14 | 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 타르트레이트 및 말레이트 염 |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR20070107043A (zh) |
CN (1) | CN101119982A (zh) |
AR (1) | AR053132A1 (zh) |
EA (1) | EA200701737A1 (zh) |
IL (1) | IL184531A0 (zh) |
TW (1) | TW200640891A (zh) |
ZA (1) | ZA200705461B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009135495A1 (en) * | 2008-05-07 | 2009-11-12 | H. Lundbeck A/S | Method for treating cognitive deficits |
TW201102370A (en) * | 2009-07-07 | 2011-01-16 | Lundbeck & Co As H | Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine |
JP2014501771A (ja) * | 2011-01-07 | 2014-01-23 | ハー・ルンドベック・アクチエゼルスカベット | 4−((1r,3s)−6−クロロ−3−フェニル−インダン−1−イル)−1,2,2−トリメチル−ピペラジンと1−((1r,3s)−6−クロロ−3−フェニル−インダン,1−イル)−3,3−ジメチル−ピペラジンとを分割するための方法 |
-
2006
- 2006-02-07 TW TW095104002A patent/TW200640891A/zh unknown
- 2006-02-14 ZA ZA200705461A patent/ZA200705461B/xx unknown
- 2006-02-14 CN CNA2006800049647A patent/CN101119982A/zh active Pending
- 2006-02-14 AR ARP060100518A patent/AR053132A1/es unknown
- 2006-02-14 KR KR1020077018678A patent/KR20070107043A/ko not_active Application Discontinuation
- 2006-02-14 EA EA200701737A patent/EA200701737A1/ru unknown
-
2007
- 2007-07-10 IL IL184531A patent/IL184531A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200701737A1 (ru) | 2007-12-28 |
CN101119982A (zh) | 2008-02-06 |
IL184531A0 (en) | 2007-10-31 |
ZA200705461B (en) | 2008-09-25 |
AR053132A1 (es) | 2007-04-25 |
TW200640891A (en) | 2006-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8110567B2 (en) | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | |
JP5553802B2 (ja) | トランス−4−((1r,3s)−6−クロロ−3−フェニルインダン−1−イル)−1,2,2−トリメチルピペラジンのコハク酸塩およびマロン酸塩、および薬剤としての使用方法 | |
KR101364365B1 (ko) | 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 제조 방법 | |
US20080269248A1 (en) | Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine | |
US8450324B2 (en) | Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine | |
KR20070107043A (ko) | 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 타르트레이트 및 말레이트 염 | |
KR101227789B1 (ko) | 트랜스-4-((1r,3s)-6-클로로-3-페닐인단-1-일)-1,2,2-트리메틸피페라진의 숙시네이트 및 말로네이트 염 및 약제로서의 용도 | |
EA007475B1 (ru) | Производные арилоксифенила и арилсульфанилфенила |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITB | Written withdrawal of application |